Closed · HT9425-23-MRP-MCAA · CFDA 12.420 · Discretionary
DoD Melanoma Mid-Career Accelerator Award
Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- September 22, 2023
- Close date
- 3
- Expected awards
The verdict
DoD Melanoma Mid-Career Accelerator Award is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 3
- expected awards
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DoD Melanoma Mid-Career Accelerator Award - is cataloged under number HT9425-23-MRP-MCAA and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on May 18, 2023. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $3.5 million in total estimated funding for this announcement. It expects to issue 3 awards. If the agency funds the expected 3 awards from the $3.5 million estimated pool, the average award works out to roughly $1.2 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on September 22, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
September 22, 2023
Posted
May 18, 2023
Est. Total Funding
$3,480,000
Expected Awards
3
Instrument
Grant
Description
The MRP MCAA supports independent, mid-career investigators conducting impactful research in the field of melanoma. The MCAA presents an opportunity for mid-career investigators with prior experience in melanoma research and/or patient care to obtain funding to continue performing impactful research that will also accelerate their career and establish them as leaders in the melanoma field. Preliminary data relevant to melanoma are required.Key aspects of the MCAA:Principal Investigator: The Principal Investigator (PI) must be a mid-career researcher or physician-scientist at the level of Assistant or Associate Professor (or equivalent). The PI must be at least 7 years from obtaining their first faculty-level appointment. Instructors and full professors (or equivalents) are not eligible. The PI must demonstrate previous receipt of at least one peer-reviewed source of extramural funding. The PI’s record of accomplishments (publications, presentations, patents, etc.) and the proposed research will be evaluated regarding the PI’s potential for contributing to the melanoma field.Impact: The impact of the proposed research must relate to at least one of the FY23 MRP Focus Areas in Section II.A.1. Impactful research, including basic research, should expedite the advancement of promising ideas towards clinical utility. The application must articulate the short- and long-term impact the proposed work will have on melanoma research and/or patient care.Continuity Plan: The goal of the MCAA is to support investigators who have laid the foundation for becoming leaders in the melanoma field and who intend to advance the state of the science in melanoma. The Continuity Plan (Attachment 7) should explain how the PI has the potential to establish themselves as a leader in the melanoma field, beyond their own laboratory or institution. Additionally, it should describe the PI’s plan for the continued development of their research program to benefit melanoma research and/or patient care.Synergy with the MRP Melanoma Academy: To enhance networking and collaboration options for both the MCAA PI and MRP Melanoma Academy Scholars, MCAA PIs will be encouraged to participate in Melanoma Academy activities (e.g., networking events, seminars hosted by the MRP Melanoma Academy Leadership) as appropriate. MCAA PIs will be required to attend one meeting hosted by the MRP Melanoma Academy Leadership during the second year of the MCAA to present project information or disseminate project results. Additional information about the Melanoma Academy can be found on the MRP website.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Dept. of the Army -- USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Department of Defense HIV/AIDS Prevention Program
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |